Health Care Select Sector SPDR® ETF (XLV)

Add to Watchlists
Create an Alert
83.71 +0.58  +0.70% NYSE Arca Dec 15, 20:00 Delayed 2m USD
View Full Chart
XLV Price Chart

XLV Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 4.11% 4.14% 3.98% 37
3M 1.76% 1.78% 0.51% 41
6M 8.75% 8.78% 8.02% 41
YTD 23.29% 23.38% 23.57% 48
1Y 22.25% 22.30% 22.13% 47
3Y 8.86% 8.84% 7.04% 35
5Y 17.54% 17.54% 17.09% 52
10Y 10.88% 10.85% 11.79% 63
As of Dec. 15, 2017. Returns for periods of 1 year and above are annualized.

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.40% 0.40% 0.00
Stock 99.60% 99.60% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of Dec. 14, 2017

XLV Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Dec. 14, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 99.32%
Industrials 0.00
Real Estate 0.00
Technology 0.68%
Utilities 0.00
As of Dec. 14, 2017

XLV Stock Market Capitalization

Giant 51.52%
Large 38.58%
Medium 9.68%
Small 0.22%
Micro 0.00
As of Dec. 14, 2017

XLV Stock Style Exposure

Large Cap Value 16.98%
Large Cap Blend 33.68%
Large Cap Growth 39.44%
Mid Cap Value 2.84%
Mid Cap Blend 2.51%
Mid Cap Growth 4.33%
Small Cap Value 0.22%
Small Cap Blend 0.00
Small Cap Growth 0.00
As of Dec. 14, 2017
View More Holdings

XLV Top 10 Holdings

Symbol Name % Weight Price % Chg
JNJ Johnson & Johnson 11.90% 142.46 +0.57%
PFE Pfizer Inc 6.81% 37.20 +2.03%
UNH UnitedHealth Group Inc 6.75% 221.82 +0.26%
ABBV AbbVie Inc 4.81% 97.45 +1.19%
MRK Merck & Co Inc 4.80% 56.24 +0.41%
AMGN Amgen Inc 4.00% 177.04 +1.21%
MDT Medtronic PLC 3.49% 83.50 +2.04%
BMY Bristol-Myers Squibb Company 3.21% 62.41 +0.45%
GILD Gilead Sciences Inc 3.04% 75.57 +1.65%
CELG Celgene Corp 2.65% 109.41 +1.08%
As of Dec. 14, 2017
Advertisement

XLV One Page Reports

XLV Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Health Care Select Sector TR USD
100.0%

XLV Manager Info

Name Tenure
Dwayne Hancock 0.74 yrs
Karl Schneider 2.67 yrs
Michael Feehily 6.67 yrs

XLV Net Fund Flows

1M -307.63M
3M -550.39M
6M -321.20M
YTD 885.06M
1Y 768.24M
3Y 2.302B
5Y 4.739B
10Y 7.148B
As of Nov. 30, 2017

XLV Risk Info

Beta (5Y) 0.9023
Max Drawdown (All) 39.17%
Historical Sharpe (10Y) 0.8028
Historical Sortino (All) 0.7193
30-Day Rolling Volatility 9.40%
Daily Value at Risk (VaR) 1% (All) 3.02%
Monthly Value at Risk (VaR) 1% (All) 13.22%

XLV Fundamentals

Dividend Yield TTM (12-15-17) 1.45%
SEC Yield (12-15-17) 1.44%
Weighted Average PE Ratio 24.06
Weighted Average Price to Sales Ratio 1.876
Weighted Average Price to Book Ratio 3.888
Weighted Median ROE 21.98%
Weighted Median ROA 7.68%
Forecasted Dividend Yield 1.62%
Forecasted PE Ratio 23.33
Forecasted Price to Sales Ratio 1.792
Forecasted Price to Book Ratio 3.545
Number of Holdings 63
As of Dec. 14, 2017

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 9.39%
Forecasted Book Value Growth 9.16%
Forecasted Cash Flow Growth 14.51%
Forecasted Earnings Growth 11.11%
Forecasted Revenue Growth 9.95%
As of Dec. 14, 2017

XLV Comparables

Edit

XLV Attributes

Key Dates
Inception Date 12/16/1998
Termination Date
Last Annual Report Date 9/30/2017
Last Prospectus Date 1/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XLV Excel Add-In Codes

  • Name: =YCI("XLV","name")
  • Broad Asset Class: =YCI("XLV", "broad_asset_class")
  • Broad Category: =YCI("XLV", "broad_category_group")
  • Prospectus Objective: =YCI("XLV", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.